BioMarin Pharmaceutical Inc. buy Barclays PLC
Start price
28.10.25
/
50%
€46.90
Target price
28.10.26
€68.62
Performance (%)
13.52%
Price
23.02.26
€53.24
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC currently has a performance of 13.52%. This prediction currently runs until 28.10.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | 5.635% | 5.635% |
| iShares Core DAX® | 0.608% | 0.340% |
| iShares Nasdaq 100 | 0.636% | -3.172% |
| iShares Nikkei 225® | -0.128% | 8.916% |
| iShares S&P 500 | 0.544% | -0.699% |
Comments by Barclays_PLC for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical (NASDAQ:BMRN) had its price target lowered by analysts at Barclays PLC from $86.00 to $80.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Barclays_PLC for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€47.65
28.01.26
28.01.26
€66.71
28.01.27
28.01.27
11.73%
23.02.26
23.02.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€62.80
04.10.24
04.10.24
€78.35
04.10.25
04.10.25
-24.70%
05.10.25
05.10.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€79.46
06.08.24
06.08.24
€100.74
06.08.25
06.08.25
-34.76%
07.08.25
07.08.25